TREACE MEDICAL CONCEPTS INC. - COMMON STOCK

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

02 Feb 2024 12:00:00 By Nasdaq GlobeNewswire

Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference

01 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue

08 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference

19 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Reports Third Quarter 2023 Financial Results

09 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

Treace to Present at Stifel 2023 Healthcare Conference

30 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Treace to Report Third Quarter 2023 Financial Results

16 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023

20 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent

14 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures

11 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference

22 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing

21 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Treace to Report Second Quarter 2023 Financial Results on August 8, 2023

18 Jul 2023 16:15:00 By Nasdaq GlobeNewswire

Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer

12 Jul 2023 16:15:00 By Nasdaq GlobeNewswire

Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System

13 Jun 2023 16:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries

01 Jun 2023 16:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Reports First Quarter 2023 Financial Results

08 May 2023 16:05:01 By Nasdaq GlobeNewswire

Treace Announces Participation in the Bank of America 2023 Healthcare Conference

26 Apr 2023 16:15:00 By Nasdaq GlobeNewswire

Treace to Report First Quarter 2023 Financial Results on May 8, 2023

20 Apr 2023 16:15:00 By Nasdaq GlobeNewswire

Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities

19 Apr 2023 16:15:00 By Nasdaq GlobeNewswire